COLLINS HELEN LOUISE (CHIEF MEDICAL OFFICER) sold 16.7% of their position (5K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $292.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/19/2026ACC: 0001701247-26-000012
Officer· CHIEF MEDICAL OFFICER
Since Feb 2026
-5K
Net shares
Net seller
$292.9K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5K
Price / share
$2.48
Trade value
$12.40K
% of position
20.0%
8/17/2026
25K→30K
Common Stock
Direct
Shares
−3.90K
Price / share
$58.37
Trade value
$227.65K
% of position
13.0%
8/17/2026
30K→26.10K
Common Stock
Direct
Shares
−1.10K
Price / share
$59.35
Trade value
$65.28K
% of position
4.2%
8/17/2026
26.10K→25K
Total
Net shares
+0.00
Net value
-$280.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +5K | $2.48 | $12.40K | 20.0% | 25K | 30K |
| Common Stock Direct | 8/17/2026 | S · Sale | −3.90K | $58.37 | $227.65K | 13.0% | 30K | 26.10K |
| Common Stock Direct | 8/17/2026 | S · Sale | −1.10K | $59.35 | $65.28K | 4.2% | 26.10K | 25K |
| Total | +0.00 | -$280.53K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
2.48
Held after
111.27K
Exercisable
—
8/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock5K shares | 8/17/2026 | M · Option Exercise | −5K | 2.48 | — | 111.27K |